Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DRRX

Durect (DRRX)

Durect Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRRX
DateTimeSourceHeadlineSymbolCompany
03/27/20244:01PMPR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
03/20/20244:30PMPR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
03/04/202411:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
03/04/20247:00AMPR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZETĀ® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
02/14/20244:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
02/07/20246:48PMPR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
12/22/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
12/01/20234:28PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
11/13/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
11/13/20234:05PMPR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
11/09/20234:30PMPR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
11/07/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
11/07/20234:01PMPR Newswire (US)DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNASDAQ:DRRXDurect Corp
09/07/20239:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
09/07/20237:00AMPR Newswire (US)DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
08/31/20234:30PMPR Newswire (US)DURECT Corporation Announces Presentations in Upcoming Investor ConferencesNASDAQ:DRRXDurect Corp
08/10/20234:21PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRRXDurect Corp
08/10/20234:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
08/09/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
08/09/20234:05PMPR Newswire (US)DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
08/03/20234:30PMPR Newswire (US)DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
07/21/20235:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
07/21/202310:38AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DRRXDurect Corp
07/20/20238:00AMPR Newswire (US)DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:DRRXDurect Corp
06/23/20235:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
06/23/20235:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
06/23/20235:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
06/23/20235:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
06/23/20235:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
06/22/20234:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRRXDurect Corp
 Showing the most relevant articles for your search:NASDAQ:DRRX